| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 15 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | yes | yes: 8, no: 7 |
| NetGPI | no | yes: 0, no: 15 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A0A3S5H764
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 2 |
| GO:0006457 | protein folding | 2 | 2 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
| GO:0018208 | peptidyl-proline modification | 6 | 2 |
| GO:0019538 | protein metabolic process | 3 | 2 |
| GO:0036211 | protein modification process | 4 | 2 |
| GO:0043170 | macromolecule metabolic process | 3 | 2 |
| GO:0043412 | macromolecule modification | 4 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0061077 | chaperone-mediated protein folding | 3 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 16 |
| GO:0003824 | catalytic activity | 1 | 16 |
| GO:0016853 | isomerase activity | 2 | 16 |
| GO:0016859 | cis-trans isomerase activity | 3 | 16 |
| GO:0140096 | catalytic activity, acting on a protein | 2 | 16 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.339 |
| CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.427 |
| CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.339 |
| CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.427 |
| CLV_PCSK_SKI1_1 | 183 | 187 | PF00082 | 0.481 |
| CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.535 |
| DOC_CYCLIN_yCln2_LP_2 | 133 | 139 | PF00134 | 0.261 |
| DOC_PP2B_LxvP_1 | 133 | 136 | PF13499 | 0.302 |
| DOC_USP7_MATH_1 | 54 | 58 | PF00917 | 0.417 |
| DOC_USP7_UBL2_3 | 143 | 147 | PF12436 | 0.232 |
| DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.356 |
| LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.546 |
| LIG_14-3-3_CanoR_1 | 37 | 42 | PF00244 | 0.400 |
| LIG_Clathr_ClatBox_1 | 64 | 68 | PF01394 | 0.307 |
| LIG_FHA_1 | 14 | 20 | PF00498 | 0.448 |
| LIG_FHA_2 | 171 | 177 | PF00498 | 0.322 |
| LIG_LIR_Apic_2 | 88 | 94 | PF02991 | 0.218 |
| LIG_LIR_Gen_1 | 129 | 139 | PF02991 | 0.279 |
| LIG_LIR_Gen_1 | 197 | 201 | PF02991 | 0.653 |
| LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.333 |
| LIG_LIR_Gen_1 | 40 | 47 | PF02991 | 0.336 |
| LIG_LIR_Nem_3 | 129 | 135 | PF02991 | 0.287 |
| LIG_LIR_Nem_3 | 197 | 201 | PF02991 | 0.653 |
| LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.432 |
| LIG_LIR_Nem_3 | 40 | 44 | PF02991 | 0.342 |
| LIG_OCRL_FandH_1 | 3 | 15 | PF00620 | 0.370 |
| LIG_PAM2_1 | 22 | 34 | PF00658 | 0.295 |
| LIG_PDZ_Class_1 | 196 | 201 | PF00595 | 0.408 |
| LIG_SH2_CRK | 41 | 45 | PF00017 | 0.313 |
| LIG_SH2_CRK | 91 | 95 | PF00017 | 0.286 |
| LIG_SH2_NCK_1 | 41 | 45 | PF00017 | 0.369 |
| LIG_SH2_SRC | 132 | 135 | PF00017 | 0.320 |
| LIG_SH2_STAP1 | 87 | 91 | PF00017 | 0.218 |
| LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.350 |
| LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.459 |
| LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.637 |
| LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.364 |
| LIG_SH2_STAT5 | 87 | 90 | PF00017 | 0.245 |
| LIG_SUMO_SIM_par_1 | 15 | 20 | PF11976 | 0.396 |
| LIG_SUMO_SIM_par_1 | 22 | 27 | PF11976 | 0.359 |
| LIG_TYR_ITIM | 196 | 201 | PF00017 | 0.524 |
| MOD_CK1_1 | 170 | 176 | PF00069 | 0.343 |
| MOD_CK1_1 | 29 | 35 | PF00069 | 0.426 |
| MOD_CK1_1 | 6 | 12 | PF00069 | 0.466 |
| MOD_CK2_1 | 170 | 176 | PF00069 | 0.335 |
| MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.407 |
| MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.320 |
| MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.326 |
| MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.351 |
| MOD_GSK3_1 | 13 | 20 | PF00069 | 0.379 |
| MOD_GSK3_1 | 167 | 174 | PF00069 | 0.368 |
| MOD_GSK3_1 | 2 | 9 | PF00069 | 0.448 |
| MOD_GSK3_1 | 22 | 29 | PF00069 | 0.388 |
| MOD_GSK3_1 | 54 | 61 | PF00069 | 0.454 |
| MOD_N-GLC_1 | 54 | 59 | PF02516 | 0.421 |
| MOD_NEK2_1 | 17 | 22 | PF00069 | 0.398 |
| MOD_NEK2_1 | 85 | 90 | PF00069 | 0.263 |
| MOD_PIKK_1 | 109 | 115 | PF00454 | 0.398 |
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.559 |
| MOD_Plk_1 | 26 | 32 | PF00069 | 0.380 |
| MOD_Plk_1 | 54 | 60 | PF00069 | 0.427 |
| MOD_Plk_4 | 13 | 19 | PF00069 | 0.402 |
| MOD_Plk_4 | 26 | 32 | PF00069 | 0.266 |
| MOD_Plk_4 | 6 | 12 | PF00069 | 0.477 |
| MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.356 |
| MOD_SUMO_rev_2 | 144 | 152 | PF00179 | 0.247 |
| TRG_DiLeu_BaEn_1 | 120 | 125 | PF01217 | 0.245 |
| TRG_ENDOCYTIC_2 | 132 | 135 | PF00928 | 0.312 |
| TRG_ENDOCYTIC_2 | 198 | 201 | PF00928 | 0.611 |
| TRG_ENDOCYTIC_2 | 41 | 44 | PF00928 | 0.368 |
| TRG_ER_diArg_1 | 107 | 109 | PF00400 | 0.312 |
| TRG_NES_CRM1_1 | 113 | 127 | PF08389 | 0.361 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HTT4 | Leptomonas seymouri | 31% | 100% |
| A0A0N1II12 | Leptomonas seymouri | 66% | 100% |
| A0A1X0P7N1 | Trypanosomatidae | 40% | 95% |
| A0A3Q8IB31 | Leishmania donovani | 30% | 100% |
| A0A3S5IR72 | Trypanosoma rangeli | 40% | 100% |
| A4H677 | Leishmania braziliensis | 31% | 100% |
| A4HA48 | Leishmania braziliensis | 77% | 100% |
| A4HUK1 | Leishmania infantum | 30% | 100% |
| A4HYB4 | Leishmania infantum | 100% | 100% |
| D0A0P0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
| E9AN99 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
| E9AS47 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
| Q09734 | Trypanosoma cruzi | 39% | 100% |
| Q4QDB9 | Leishmania major | 96% | 100% |
| Q4QHC5 | Leishmania major | 30% | 100% |
| Q9JYI8 | Neisseria meningitidis serogroup B (strain MC58) | 29% | 74% |